How do you solve a problem like multidrug-resistant Gram-negative bacteria?

Journal of Hospital Infection

Volumn 92, Issue 1, 2016, Pages 1-2

  Gray, J W ^a   Mahida, N ^b  

^a Hospital Infection Society   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HYDROGEN PEROXIDE;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CLEANING; COMORBIDITY; EDITORIAL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAND WASHING; HEALTH CARE COST; HUMAN; INFECTION PREVENTION; MORTALITY; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANCE GRAM NEGATIVE BACTERIA; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; CROSS INFECTION; DISEASE TRANSMISSION; DRUG EFFECTS; GLOBAL HEALTH; GRAM-NEGATIVE BACTERIAL INFECTIONS; INFECTION CONTROL; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREVENTION AND CONTROL; PROCEDURES;

CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GLOBAL HEALTH; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL;

EID: 84952975111     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2015.11.005     Document Type: Editorial

References (17)

1. Wilson A.P.R., Livermore D.M., Otter J.A., et al. Prevention and control of multidrug-resistant (MDR) Gram-negative bacteria - recommendations from a Joint Working Party. J Hosp Infect 2016, 92(S1):S1-S44.
2. Hoxha A., Kärki T., Giambi C., et al. Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013. J Hosp Infect 2016, 92:61-66.
3. Maslikowska J.A., Walker S.A.N., Elligsen M., et al. Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs. J Hosp Infect 2016, 92:33-41.
4. Cole J. Antimicrobial resistance - a 'rising tide' of national (and international) risk. J Hosp Infect 2016, 92:3-4.
5. World Health Organization Antimicrobial resistance: global report on surveillance 2014, WHO, Geneva.
6. Ambrogi V., Cavalié L., Mantion B., et al. Transmission of metallo-β-lactamase producing Pseudomonas aeruginosa in a nephrology-transplant intensive care unit with potential link to the environment. J Hosp Infect 2016, 92:27-29.
7. Rastogi N., Mathur P., Bindra A., et al. Infections due to Elizabethkingia meningoseptica in critically injured trauma patients: a 7-year study. J Hosp Infect 2016, 92:30-32.
8. Zenati K., Touati A., Bakour S., Sahli F., Rolain J.M. Characterization of NDM-1- and OXA-23-producing Acinetobacter baumannii isolates from inanimate surfaces in a hospital environment in Algeria. J Hosp Infect 2016, 92:19-26.
9. Hopman J., Hakizimana B., Meintjes M.A.T., et al. Manual cleaning of hospital mattresses: an observational study between high- and low-resource settings. J Hosp Infect 2016, 92:14-18.
10. Alsaffar L., McCrudden P.R., Hayter R., Kavanagh M. Duodenoscope decontamination validation study. J Hosp Infect 2016, 92:110-111.
11. Muller M.P., MacDougall C., Lim M. Antimicrobial surfaces to prevent healthcare-associated infections (HAI): a systematic review. J Hosp Infect 2016, 92:7-13. the Ontario Agency for Health Protection and Promotion (Public Health Ontario), the Provincial Infectious Disease Advisory Committee on Infection Prevention and Control (PIDAC-IPC).
12. Karaaslan A., Soysal A., Altinkanat Gelmez G., Kepenekli Kadayifci E., Söyletor G., Bakir M. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey. J Hosp Infect 2016, 92:67-72.
13. Moghnieh R., Siblani L., Ghadban D., et al. Extensively drug-resistant Acinetobacter baumannii in a Lebanese intensive care unit: risk factors for acquisition and determination of a colonization score. J Hosp Infect 2016, 92:47-53.
14. Clarivet B., Pantel A., Morvan M., et al. Carbapenemase-producing Enterobacteriaceae: use of a dynamic registry of cases and contacts for outbreak management. J Hosp Infect 2016, 92:73-77.
15. Guyot A. Benefits of NICE accreditation for guidelines. J Hosp Infect 2016, 92:5-6.
16. Wilson A.P.R. Multidrug-resistant (MDR) Gram-negative bacteria information leaflets. J Hosp Infect 2016, 92:86-87.
17. Poole K., George R., Shryane T., et al. Evaluation of patient-held carbapenemase-producing Enterobacteriaceae (CPE) alert card. J Hosp Infect 2016, 92:102-105.